Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025)

Perspective Therapeutics recorded quarterly Other Non Operating Income of $1.4 million in Q1 2025, up 69900.0% quarter-over-quarter from $2000.0 in Q2 2023.

Perspective Therapeutics' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $1.4 million for Q1 2025.

  • In Q1 2025, Other Non Operating Income changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, changed N/A from the prior year.
  • Other Non Operating Income came in at $1.4 million for Q1 2025 at Perspective Therapeutics, up from $2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of $2000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 1.40 Mn
Jun 30, 2023 2,000.00
Mar 31, 2019 2,000.00
Sep 30, 2016 27,000.00
Jun 30, 2016 18,000.00
Mar 31, 2016 78,000.00
Sep 30, 2015 15,000.00
Jun 30, 2015 -605.00
Mar 31, 2015 28,605.00
Dec 31, 2014 41,000.00
Sep 30, 2014 306,000.00
Jun 30, 2014 -368,134.00
Mar 31, 2014 -1.10 Mn
Dec 31, 2013 117,000.00
Sep 30, 2013 -36,000.00
Jun 30, 2013 25,000.00
Mar 31, 2013 109,000.00
Dec 31, 2012 -55,000.00
Sep 30, 2012 -11,000.00
Jun 30, 2012 18,650.00
Mar 31, 2012 -194,445.00
Dec 31, 2011 10,000.00
Jun 30, 2011 77,000.00
Mar 31, 2011 79,000.00
Dec 31, 2010 -259,000.00